Imagion Biosystems has released “Preliminary Report and Appendix 4E for the year ended 31 December 2018.
View Appendix 4E and Preliminary Report.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell